Question 1

What is Retatrutide used for?

Accepted Answer

Retatrutide (brand name Retatrutide) is a GLP-1/GIP/Glucagon Agonist indicated for Obesity (Phase 3), Type 2 Diabetes (Phase 3).

Question 2

How does Retatrutide work?

Accepted Answer

Retatrutide works through the following mechanism: Triple incretin agonist targeting GLP-1, GIP, and glucagon receptors simultaneously for enhanced metabolic effects..

Question 3

What are the most common side effects of Retatrutide?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for Retatrutide. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is Retatrutide the same as Retatrutide?

Accepted Answer

Retatrutide is a brand name for Retatrutide. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

Retatrutide

Mechanism of Action

Indications

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations